• 1
    Thompson NW, Nishiyama RH, Harness JK. Thyroid carcinoma: Current controversies. Curr Probl Surg 1978; 15:167.
  • 2
    Beierwaltes WH. The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med 1978; 8:7994.
  • 3
    Tubiana M. External radiotherapy and radioiodine in the treatment of thyroid cancer. World J Surg 1981; 5:7584.
  • 4
    Rougier P, Parmentier C, Laplanche A et al. Medullary thyroid carcinoma: Prognostic factors and treatment. Int J Radiat Oncol Biol Phys 1983; 9:161169.
  • 5
    Rougier P, Calmettes C, Laplanche A et al. The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma. Cancer 1983; 51:855862.
  • 6
    Cady B, Sedgwick CE, Meissner WA, Wool MS, Salzman FA, Werber J. Risk factor analysis in differentiated thyroid cancer. Cancer 1979; 43:810820.
  • 7
    Franssila KO. Prognosis in thyroid carcinoma. Cancer 1975; 36:11381146.
  • 8
    Gerard-Marchant R, Bok B. Cancer of the thyroid: Prognostic factors and criteria of response. In: StaquetMJ, ed. Cancer Therapy: Prognostic Factors and Criteria of Response. Raven Press: New York, 1975; 367.
  • 9
    Halnan KE. Influence of age and sex on the incidence and prognosis of thyroid cancer. Cancer 1966; 19:15341536.
  • 10
    Howard RB, Truels WP. Thyroid cancer: 30 years review of 201 cases. Am J Surg 1979; 138:934938.
  • 11
    Ito J, Noguchi S, Murakami N, Noguchi A. Factors affecting the prognosis of patients with carcinoma of the thyroid. Surg Gynecol Obstet 1980; 150:539544.
  • 12
    Mazzaferri EL. Papillary and follicular thyroid cancer. Ann Rev Med 1981; 32:7391.
  • 13
    Russell MA, Gilbert EF, Jaeschke WF. Prognostic features of thyroid cancer: A long-term follow-up of 68 cases. Cancer 1975; 36:553559.
  • 14
    Staunton MD, Skeet RG. Thyroid cancer prognosis in 469 patients. Br J Surg 1979; 66:643647.
  • 15
    Woolner LB, Beahrs OH, Black BM, McConahey WM, Keating FR Jr. Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a 30 yr period. Am J Surg 1961; 102:354387.
  • 16
    Woolner LB. Thyroid carcinoma: Pathologic classification with data on prognosis. Semin Nucl Med 1971; 1:481502.
  • 17
    Samaan NA, Mahesh Wary YK, Nader S et al. Impact of therapy for differentiated carcinoma of the thyroid: An analysis of 706 cases. J Clin Endocrinol Metab 1983; 56:11311137.
  • 18
    Byar DP, Green SB, Dor P et al. A prognostic index for thyroid carcinoma: A study of the E.O.R.T.C. thyroid cancer cooperative group. Eur J Cancer 1979; 15:10331041.
  • 19
    Fourquet A, Asselain B, Joly J. Cancer de la thyroide. Analyse multidimensionnelle des facteurs pronostiques. Ann Endocrinol 1983; 44:121126.
  • 20
    Lacour J, Gerard-Marchant R, Genin J. Diagnostic et traitement chirurgical des cancers thyroidiens primitifs. J Chir (Paris) 1966; 92:331350.
  • 21
    Lacour J, L'Heritier C, Petit JY et al. Surgical treatment of differentiated thyroid cancer at the Institut Gustave-Roussy. Ann Radiol (Paris) 1977; 20:767770.
  • 22
    Tubiana M, Perez R, Parmentier C, Monnier JP. La survie des cancers thyroïdiens traités par iode radioactif: A propos de 147 cas suivis pendant plus de 5 ans. Presse Med 1968; 76:19992002.
  • 23
    Tubiana M, Lacour J, Monnier JP et al. External radiotherapy and radioiodine in the treatment of 359 thyroid cancers. Br J Radiol 1975; 48:894907.
  • 24
    Tubiana M, Charbord P, Cukersztein W, Sarrazin D, Fontaine F, Parmentier C. The role of radiotherapy and radioactive iodine in the treatment of thyroid cancer without metastases. Ann Radiol (Paris) 1977; 20:801805.
  • 25
    Hedinger LE, Sobin LH. Histological typing of thyroid tumors, vol. 11. International Histological Classification of Tumors Geneva: WHO, 1974.
  • 26
    Cabanne F, Gerard-Marchant R, Heimann B, Williams ED. Tumeurs malignes du corps thyroide: Problèmes de diagnostic histopathologique. Ann Anat Path 1974; 19:129148.
  • 27
    Busnardo B, Vangelista R, Girelli ME, Bui F, Lazzi C. TSH levels and TSH response to TRH as a guide to the replacement treatment of patients with thyroid carcinoma. J Clin Endocrinol Metab 1976; 42:901906.
  • 28
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457481.
  • 29
    Peto E, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I: Introduction and design. Br J Cancer 1976; 34:585612. II: Analysis and examples. Br J Cancer 1977; 35:139.
  • 30
    I,N,S,E,E. Statistique du mouvement de la population. Les causes de décès. Années 1950 à 1967. Paris: I.N.S.E.E.
  • 31
    I,N,S,E,R,M. Statistique des causes médicales de décès. Tome I, Résultats France. Années 1968 à 1978. Paris: I.N.S.E.R.M.
  • 32
    Monson RR. Analysis of relative survival and proportional mortality. Comput Biomed Res 1974; 7:325332.
  • 33
    Breslow NE, Lubin JH, Marek P, Langholz B. Multiplicative models and cohort analysis. J Am Stat Assoc 1983; 78:112.
  • 34
    Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley and Sons, 1980.
  • 35
    Cox DR. Regression models and life tables. J R Stat Soc (B) 1972; 34:187220.
  • 36
    Kay R. Proportional hazard regression models and the analysis of censored survival data. Appl Stat 1977; 26:227237.
  • 37
    Gardet P, Parmentier C, Gerard-Marchant R et al. Differentiated cancer of the thyroid: Course after treatment with special reference to frequency and chronology of the first relapse for 470 treated patients. Ann Radiol (Paris) 1977; 20:831840.
  • 38
    Charbord P, L'Heritier C, Cukersztein W, Lumbroso J, Tubiana M. Radioiodine treatment in differentiated thyroid carcinomas: Treatment of first local recurrences and of bone and lung metastases. Ann Radial (Paris) 1977; 20:783786.
  • 39
    Leeper RD. The effect of 131 I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma. J Clin. Endocrinol Metab 1973; 36:11431152.
  • 40
    Buckwalter JA, Thomas CG, Freeman JB. Is childhood thyroid cancer a lethal disease? Ann Surg 1975; 181:632639.
  • 41
    Winship T, Rosvoll RV. Thyroid carcinoma in childhood: Final report on a 20 year study. Proc Natl Cancer Conf 1970; 6:677681.
  • 42
    Verby JE, Woolner LB, Nobrega T, Karkland LT, McConahey WM. Thyroid cancer in Olmsted county (1935–1965). J Natl Cancer Inst 1969; 43:813820.
  • 43
    Simpson WJ, Carruthers JS. The role of external radiation in the management of papillary and follicular thyroid cancer. Am J Surg 1978; 136:457460.
  • 44
    McConahey WM, Taylor WF, Gorman CA, Woolner LB. Retrospective study of 820 patients treated for papillary carcinoma of the thyroid at the Mayo Clinic between 1946 and 1971. In: Advances in Thyroid Neoplasia. Rome Field Educational Italia, 1981; 245262.
  • 45
    Maheshwari YK, Hill SC, Haynie TP, Hickey RC, Samaan NA. 131 I therapy in differentiated thyroid carcinoma: Cancer 1981; 47:664671.
  • 46
    McKenzie AD. The natural history of thyroid cancer. Arch Surg 1971; 102:274277.
  • 47
    Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP. Papillary thyroid carcinoma: The impact of therapy in 576 patients. Medicine 1977; 56:171196.
  • 48
    Young RL, Mazzaferri EL, Rahe AJ, Dorfman SG. Pure follicular thyroid carcinoma: Impact of therapy in 214 patients. J Nucl Med 1980; 21:733737.
  • 49
    Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 1978; 136:107110.
  • 50
    Varma VM, Beierwaltes WH, Nofal MM, Nishiyama RH, Copp JE. Treatment of thyroid cancer: Death rates after surgery and after surgery followed by sodium iodine 131 I. JAMA 1970; 214:14371442.
  • 51
    Hubert JP, Kiernan PD, Beahrs OH, McConahey WM, Woolner LB. Occult papillary carcinoma of the thyroid. Arch Surg 1980; 115:394398.
  • 52
    Beierwaltes WH, Nishiyama RH, Thompson NW, Copp JE, Kubo A. Survival time and cure in papillary and follicular thyroid carcinoma with distant metastases: Statistics following University of Michigan Therapy. J Nucl Med 1982; 23:561568.
  • 53
    Parmentier C, Aubert B, Charbord P, Fragu P, Gardet P. Follow-up of differentiated thyroid cancers after treatment: Resume and practical guide to the development of follow-up programs. Ann Radiol (Paris) 1977; 20:841855.
  • 54
    Tubiana M, Mabille JP. L'iode radioactif et le cancer de la thyroïde. Problèmes diagnostiques. J Radiol Electrol (Paris) 1963; 44:179186.
  • 55
    Turner JE, Weier GJ Jr. Pulmonary metastases from thyroid carcinoma detectable only by 131 I scan. Treatment and response. J Nucl Med 1972; 13:852855.
  • 56
    Schlumberger M, Charbord P, Fragu P et al. Relationship between thyrotropin stimulation and radioiodine uptake in lung metastases of differentiated thyroid carcinoma. J Clin Endocrinol Metab 1983; 57:148151.
  • 57
    Schlumberger M, Fragu P, Parmentier C, Tubiana M. Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas: Comparison of its value in patients with or without normal residual tissue. Acta Endocrinol (Kbh) 1981; 98:215221.
  • 58
    Van Herle AJ, Uller RP. Elevated serum thyroglobulin: A marker of metastases in differentiated thyroid carcinomas. J Clin Invest 1975; 56:272277.
  • 59
    Schlumberger M, Charbord P, Fragu P, Lumbroso J, Parmentier C, Tubiana M. Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: Relationship to serum thyrotropin levels. J Clin Endocrinol Metab 1980; 51:513519.
  • 60
    Clark OH. TSH suppression in the management of thyroid nodules and thyroid cancer. World J Surg 1981; 5:3947.
  • 61
    Charbit A, Malaise E, Tubiana M. Relations between the pathological nature and the growth rate of human tumours. Eur J Cancer 1971; 7:307315.
  • 62
    Tubiana M. Cell kinetics and radiation oncology. Int J Radiat Oncol Biol Phys 1982; 8:14711489.
  • 63
    Carayon P, Thomas-Morvan C, Castanas E, Tubiana M. Human thyroid cancer: Membrane thyrotrophin binding and adenylate cyclase activity. J Clin Endocrinol Metab 1980; 51:915920.
  • 64
    Thomas-Morvan C, Carayon P, Schlumberger M, Vignal A, Tubiana M. Thyrotrophin stimulation of adenylate cyclase and iodine uptake in human differentiated thyroid cancer. Acta Endocrinol (Kbh) 1982; 101:2531.